Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Starboard Value
CRO
Starboard targets Parexel amid talk of multibillion-dollar sale
Activist investor Starboard Value is demonstrating its confidence in Parexel by disclosing a 5.7% stake buy in the company, immediately after news of the CRO’s potential $4 billion sale went out on the street.
Angus Liu
May 11, 2017 9:16am
UPDATED: Angry Depomed investor seeks to oust company’s board
May 26, 2016 10:03am